Filtered By:
Cancer: Acute Lymphoblastic Leukemia
Vaccination: Meningitis Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 8 results found since Jan 2013.
Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome
CONCLUSIONS: Acute lymphoblastic leukemia, vaccines against hepatitis A and meningococci can be included among antecedent factors in OMAS. Among clinical symptoms, speech problems might point to the likelihood of an underlying neoplasm in OMAS. Intravenous immunoglobulin and steroids may be chosen for initial treatment while rituximab can increase the chance of recovery in case of persistent or recurrent symptoms. The presence of relapse was associated with poor outcome.PMID:36155293 | DOI:10.1016/j.ejpn.2022.09.002
Source: European Journal of Paediatric Neurology - September 26, 2022 Category: Neurology Authors: Mira ç Yıldırım İbrahim Öncel Ömer Bektaş Gizem Tanal ı S üleyman Şahin Tezer Kutluk Serap Teber Banu Anlar Source Type: research
